CEO of Device Access UK, Michael Branagan-Harris gathers a panel of NHS management to discuss the future of MedTech Engagement with the NHS in the wake of Covid-19 and how best to approach it.  Device Access UK helps MedTech companies all over the world demonstrate the true value of their device, to help in getting great technologies to patients faster.

CEO of Device Access UK, Michael Branagan-Harris gathers a panel of NHS management to discuss the future of MedTech Engagement with the NHS in the wake of Covid-19 and how best to approach it. Device Access UK helps MedTech companies all over the world demonstrate the true value of their device, to help in getting great technologies to patients faster.

CEO of Device Access UK, Michael Branagan-Harris gathers a panel of NHS management to discuss the future of MedTech Engagement with the NHS in the wake of Covid-19 and how best to approach it.&nbsp; Device Access UK helps MedTech companies all over the world demonstrate the true value of their device, to help in getting great technologies to patients faster.&nbsp;

NHS MedTech Market Access Engagement Post Covid 19 Series

How to get great Medical Technologies to patients faster in the UK National Health Service (NHS) and accelerate adoption through real world evidence and health economics to gain recommendation of use  though NICE - the NHS HTA body.

Science

Life Sciences

How to get great Medical Technologies to patients faster in the UK National Health Service (NHS) and accelerate adoption through real world evidence and health economics to gain recommendation of use though NICE - the NHS HTA body.

Share NHS MedTech Market Access Engagement Post Covid 19 Series

Sign up to save your podcasts

NHS MedTech Market Access Engagement Post Covid 19 Series

NHS MedTech Market Access Engagement Post Covid 19 Series